SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
SEC Accession No. 0001753926-24-000268
Filing Date
2024-02-12
Accepted
2024-02-12 08:09:16
Documents
25

Document Format Files

Seq Description Document Type Size
1 FWP g084030_fwp.htm FWP 34478
2 GRAPHIC img001.jpg GRAPHIC 388303
3 GRAPHIC img002.jpg GRAPHIC 912073
4 GRAPHIC img003.jpg GRAPHIC 313631
5 GRAPHIC img004.jpg GRAPHIC 277755
6 GRAPHIC img005.jpg GRAPHIC 70738
7 GRAPHIC img006.jpg GRAPHIC 52565
8 GRAPHIC img007.jpg GRAPHIC 132461
9 GRAPHIC img008.jpg GRAPHIC 52792
10 GRAPHIC img009.jpg GRAPHIC 68302
11 GRAPHIC img010.jpg GRAPHIC 65498
12 GRAPHIC img011.jpg GRAPHIC 67512
13 GRAPHIC img012.jpg GRAPHIC 90336
14 GRAPHIC img013.jpg GRAPHIC 94416
15 GRAPHIC img014.jpg GRAPHIC 76002
16 GRAPHIC img015.jpg GRAPHIC 75978
17 GRAPHIC img016.jpg GRAPHIC 57199
18 GRAPHIC img017.jpg GRAPHIC 50933
19 GRAPHIC img018.jpg GRAPHIC 81682
20 GRAPHIC img019.jpg GRAPHIC 70414
21 GRAPHIC img020.jpg GRAPHIC 99854
22 GRAPHIC img021.jpg GRAPHIC 89600
23 GRAPHIC img022.jpg GRAPHIC 56527
24 GRAPHIC img023.jpg GRAPHIC 122712
25 GRAPHIC img024.jpg GRAPHIC 78327
  Complete submission text file 0001753926-24-000268.txt   4783996
Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Filed by) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Subject) CIK: 0001919246 (see all company filings)

IRS No.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: FWP | Act: 34 | File No.: 333-269188 | Film No.: 24617441
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)